| ||||||||||||||
|
|
|||||||||||||

*Pain Management and Research Center, University of Sydney, and
Spinal Injuries Unit, Royal North Shore Hospital, St. Leonards, NSW, Australia
Address correspondence and reprint requests to Philip J. Siddall, MB, BS, MMed (PM), PhD, Pain Management & Research Center, Royal North Shore Hospital, St. Leonards NSW, Australia 2065. Address e-mail to phils{at}med.usyd.edu.au
We performed a double-blinded, randomized, controlled trial in 15 patients to determine the efficacy of intrathecal morphine or clonidine, alone or combined, in the treatment of neuropathic pain after spinal cord injury. The combination of morphine and clonidine produced significantly more pain relief than placebo 4 h after administration; either morphine or clonidine alone did not produce as much pain relief. In addition, lumbar and cervical cerebrospinal fluid (CSF) concentrations, sampled at these levels at different times after administration were examined for a relationship between pain relief and CSF drug concentration. Lumbar CSF drug concentrations were initially several orders of magnitude larger than those in cervical CSF. After 12 h, the concentrations of morphine in cervical CSF markedly exceeded those of clonidine. The concentration of morphine in the cervical CSF and the degree of pain relief correlated significantly. We conclude that intrathecal administration of a mixture of clonidine and morphine is more effective than either drug administered alone and is related to the CSF-borne drug concentration above the level of spinal cord injury. If there is pathology that may restrict CSF flow, consideration should be given to intrathecal administration above the level of spinal cord damage to provide an adequate drug concentration in this region.
Implications: Neuropathic pain after spinal cord injury is very difficult to control adequately by using currently available techniques. We have performed a placebo-controlled, double-blinded study demonstrating that administration of a combination of morphine and clonidine into the spinal fluid can provide substantial pain relief in some people with this type of pain.
This article has been cited by other articles:
![]() |
V. L. Ghafoor, M. Epshteyn, G. H. Carlson, D. M. Terhaar, O. Charry, and P. K. Phelps Intrathecal drug therapy for long-term pain management Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2447 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Parisod, P. J. Siddall, M. Viney, J. M. McClelland, and M. J. Cousins Allodynia After Acute Intrathecal Morphine Administration in a Patient with Neuropathic Pain After Spinal Cord Injury Anesth. Analg., July 1, 2003; 97(1): 183 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Sites, M. Beach, R. Biggs, C. Rohan, C. Wiley, A. Rassias, J. Gregory, and G. Fanciullo Intrathecal Clonidine Added to a Bupivacaine-Morphine Spinal Anesthetic Improves Postoperative Analgesia for Total Knee Arthroplasty Anesth. Analg., April 1, 2003; 96(4): 1083 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. McMillan, T. Doud, and W. Nugent Catheter-Associated Masses in Patients Receiving Intrathecal Analgesic Therapy Anesth. Analg., January 1, 2003; 96(1): 186 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Walker, L. C. Goudas, M. J. Cousins, and D. B. Carr Combination Spinal Analgesic Chemotherapy: A Systematic Review Anesth. Analg., September 1, 2002; 95(3): 674 - 715. [Full Text] [PDF] |
||||
![]() |
N. Attal, F. Guirimand, L. Brasseur, V. Gaude, M. Chauvin, and D. Bouhassira Effects of IV morphine in central pain: A randomized placebo-controlled study Neurology, February 26, 2002; 58(4): 554 - 563. [Abstract] [Full Text] [PDF] |
||||
|